Top Markets
#1 Akedo Akedo +57.68%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.31%
#4 Cross Cross +43.97%
#5 OVERTAKE OVERTAKE +34.90%
#6 Black Phoenix Black Phoenix +34.01%
#7 Velvet Velvet +27.53%
#8 Cap Cap +15.60%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.31%
#10 Palladium Network Palladium Network +12.56%
Coin of the day
Akedo Akedo
設定
言語
日本
通貨
USD
テーマ
Analytica Limited Analytica Limited

Analytica Limited

ALT
株式のランク #39133
Established in 1985 and based in Brisbane, Australia, Analytica Limited is a... Established in 1985 and based in Brisbane, Australia, Analytica Limited is a medical device company that designs, develops, and distributes healthcare solutions across Australia, China, and the Middle East. Its flagship product is the PeriCoach system, an innovative e-health platform designed for women to manage stress urinary incontinence. This comprehensive system consists of a specialized device, a web portal, and a smartphone application, all working together to monitor pelvic floor muscle activity. Additionally, the company offers the Autostart Burette Infusion System, which is used for the automated monitoring and replenishment of burettes during intravenous fluid administration.
株価
$0.00066127
最終同期: 2023-05-23
時価総額
$636.20K
変化（1日）
-0.56%
変化（1年）
0.00%
国
AU
取引 Analytica Limited (ALT)

カテゴリー

Healthcare
Analytica Limited（ALT）の収益
Aug 2026 時点の収益 TTM: 0
Analytica Limited の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Analytica Limited の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US